BGA
GNMX
Belmont Global Advisors’s Aevi Genomic Medicine, Inc. GNMX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-20,000
| Closed | -$111K | – | 78 |
|
|
2016
Q2 | $111K | Buy |
+20,000
| New | +$111K | 0.11% | 55 |
|
|
2016
Q1 | – | Sell |
-65,000
| Closed | -$391K | – | 90 |
|
|
2015
Q4 | $391K | Sell |
65,000
-90,000
| -58% | -$541K | 0.51% | 47 |
|
|
2015
Q3 | $1.21M | Buy |
155,000
+118,800
| +328% | +$929K | 2.06% | 11 |
|
|
2015
Q2 | $222K | Buy |
36,200
+6,200
| +21% | +$38K | 0.25% | 89 |
|
|
2015
Q1 | $242K | Buy |
30,000
+10,000
| +50% | +$80.7K | 0.25% | 71 |
|
|
2014
Q4 | $101K | Sell |
20,000
-143,347
| -88% | -$724K | 0.1% | 104 |
|
|
2014
Q3 | $848K | Sell |
163,347
-176,653
| -52% | -$917K | 0.66% | 47 |
|
|
2014
Q2 | $2.64M | Hold |
340,000
| – | – | 1.91% | 12 |
|
|
2014
Q1 | $2.37M | Buy |
340,000
+10,000
| +3% | +$69.8K | 1.99% | 13 |
|
|
2013
Q4 | $1.98M | Buy |
+330,000
| New | +$1.98M | 1.6% | 15 |
|